Stock SAGE SAGE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Sage Therapeutics, Inc.

Equities

SAGE

US78667J1088

Market Closed - Nasdaq
Other stock markets
 04:00:04 2024-07-12 pm EDT 		5-day change 1st Jan Change
11.76 USD +0.21% Intraday chart for Sage Therapeutics, Inc. +9.09% -45.73%
Jul. 12 JPMorgan Lowers Price Target on Sage Therapeutics to $18 From $23, Maintains Overweight Rating MT
Jul. 09 RBC Cuts Price Target on Sage Therapeutics to $12 From $15, Keeps Sector Perform Rating MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. SAGE Stock
  4. Revisions Sage Therapeutics, Inc.